BioScience Laboratories Announces Clinical Studies Capabilities for H1N1 Influenza

    BOZEMAN, MT, October 01, 2009 /24-7PressRelease/ -- BioScience Laboratories has received approval from the Gallatin Institutional Review Board to test antiviral efficacy against H1N1 influenza A/Brisbane/59/2007, IVR-148 using healthy human subjects. These surrogate clinical trials will be conducted via ASTM E1838 (finger-pad method) and ASTM E2011 (whole hand method).

The combination of BioScience Laboratories' 18 years of clinical studies experience and its in-vitro virology laboratory that has tested over 50 products in 2009 for their efficacy against H1N1 provides a complete solution to product manufacturers for virucidal testing.

About BioScience Laboratories

BioScience Laboratories, Inc. was founded in 1991 in Bozeman, MT, to provide antimicrobial product testing and result interpretation grounded in science. Bioscience Laboratories Inc. strives to assist its clients in strengthening their current market positions through product testing and aid in the development of new products and new markets. Today, BioScience Laboratories offers a variety of state-of-the-art laboratory services and guidance regarding federal regulatory agency requirements for the healthcare, pharmaceutical, personal care and consumer products markets.

Website: http://www.biosciencelabs.com

# # #